Autotaxin (ATX), an established drug target in IPF, is a secreted lysophospholipase D that catalyzes the extracellular production of lysophosphatidic acid (LPA), a growth-factor-like signaling phospholipid. This evidence concerns the gene ENPP2 and idiopathic pulmonary fibrosis.